CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Bio Preventive Medicine Corp is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Bio Preventive Medicine Corp
6F-1, No. 18 Taiyuan Street
Phone: +886 35601816p:+886 35601816 ZHUBEI, 302  Taiwan Ticker: 68106810
Business Summary
Bio Preventive Medicine Corp is a Taiwan-based company mainly engaged in the research, development, manufacture and sale of medical testing reagents, as well as the provision of testing services. The main products are in vitro testing reagents, which are mainly used in the early detection and prevention of diabetes complications, chronic kidney diseases and other chronic diseases, and cancers. The Company operates in North America, Europe, Asia and South America markets.
(Source: PROSPECTUS)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202312/31/2023Yes----

Industries
SIC Code Description
2835 In vitro and in vivo diagnostic substances
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, General Manager ZilingZeng 1/19/2022 6/23/2014
Deputy General Manager-Business Marketing YuhuaZeng 5/16/2023 5/16/2023
Head of Finance & Accounting ZuxunGuo 8/11/2022 8/11/2022
5 additional Officers and Directors records available in full report.

General Information
Outstanding Shares: 34,449,000 (As of 12/31/2023)
Stock Exchange: TPO
Fax Number: +886 35601916


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, April 19, 2024